Pharmotech Sais A Geneva Based Swiss Laboratory Focused Primarily On The Phyto Research And Development Of Pharmacological Antibacterial Applications Of Cannabidiolcbdon Multidrug Resistantmdrbacteriawith A Specific Focus On Pseudomonas Aeruginosathe Company Is Collaborating With Academic Research Partnersuniversity Of Genevaunigeand Fribourgunifand The Sichh Instituteto Conduct Multiple Studies On The Complicated Pathologies Of Bacterial Contamination And Its Eradicationpharmotech Sa Intends To Become A Leading Pharmaceutical Player In The Global Production And Distribution Of Cannabinoidscbdbased Medical Products For Antibacterial Applications Cannabidiol Is One Of The More Than 85 Cannabinoids So Far Identified In Marijuana And Hempnumerous Studies Have Shown That Cbd Possesses An Extraordinary Array Of Therapeutic Benefitsincluding Antioxidant And Neuroprotective Propertiescannabinoids Are Used In The Formulation Of Numerous Products Marketed As Nutritional Supplementsherbal Medicinescosmeticsand Therapeutics Pharmotech Has Targeted Cbd As An Antibacterial Topical Application To Prevent Critical Health Issues Caused By Bacteriawhich Has Become More Antibiotic Resistant Over Timethe Company S Preliminary Research Has Recorded Very Promising Outcomes In The Development Of An Innovativeall Natural Cbd Based Antibacterial Formulation To Preventand Cure Bacterial Infectionsthis Preliminary Research Has Been Positively Backed By A In Vivo Study And A Pre Clinical Analysis Recently Performed At Chuvcentre Hospitalaire Universitaire Vaudois Before The End Of 2018The Clinical Trials Required For Pharmotech S Technology To Become A Medical Device Will Begin
No conferences found for this company.
| Company Name | Pharmotech Sa |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
